WHRI ACADEMY fellowship programme: THIRD CALL FOR PROPOSALS at WHRI QMUL
DEADLINE for submission of proposals: 24 April 2015, 17h00 UK time
The Third Call for Proposals of the William Harvey International Translational Research Academy programme (WHRI-ACADEMY) was launched in January 2015.
All the documentation related to the Third Call for Proposals is available in the “Application pack” section of the project’s website: www.whri-academy.eu
To be eligible, the candidates:
1) Must be in possession of a PhD degree or have at least 4 years of full-time research experience
2) Must not have resided or carried out his/her main activity in the chosen host country for more than 12 months in the last 3 years prior of the deadline for submission of applications
3) Must choose a host lab among the institutions already enrolled in our programme – http://www.whri-academy.eu/host-organisations
4) The chosen Supervisor must match the COFUND contribution. Please note that the COFUND contribution is a flat-rate, fixed amount per fellow-year (€29,800.00 multiplied by the Marie Curie country corrector coefficient)
For further details and or clarifications:












BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Celebrate World Wellbeing Week This June
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease